Biocon launches Tacrolimus capsules in US

Image
Capital Market
Last Updated : Dec 28 2020 | 4:50 PM IST
Biocon announced the launch of Tacrolimus capsules in the US. Tacrolimus, a calcineurin inhibitor, is an immunosuppressant used in the treatment of organ transplant patients, which reduces the body's ability to reject a transplanted organ. It has been particularly effective in treating patients of renal transplant for more than two decades.

The launch of Tacrolimus capsules, following an approval from the US FDA in November 2020.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Dec 28 2020 | 4:44 PM IST

Next Story